We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...

Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Avior Wealth Management LLC boosted its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 10.4% during the 4th quarter, according to the company in its most recent filing with the ...

Before making this announcement, Elevance Health was easily earning enough to cover the dividend. As a result, a large proportion of what it earned was being reinvested back into the business.

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 5.53%, which ...

Analysts' ratings for Elevance Health (NYSE:ELV) over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below illustrates ...